Aristides Capital’s MaxLinear MXL Stock Holding History

Aristides Capital’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,107	Closed	-$312K	–	325
2023 Q4	$312K	Buy	+13,107	New	+$257K	0.11%	120

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aristides Capital's MXL Position: Q1 2024 in Review

Aristides Capital sold out of MaxLinear (MXL) in Q1 2024, closing a stake of 13,107 shares — an estimated $312K sold.

Aristides Capital first reported a position in MXL in Q4 2023 and held it in 1 quarter. The position peaked at $312K in Q4 2023. 209 funds tracked by Wall St. Rank hold MXL as of Q1 2024.

Aristides Capital reported no remaining MaxLinear position as of Q1 2024 after selling out during the quarter.
Aristides Capital sold 13,107 MaxLinear shares in Q1 2024, an estimated $312K.
Aristides Capital first reported a position in MaxLinear in Q4 2023 and held it in 1 quarter.
Aristides Capital's MaxLinear position peaked at $312K in Q4 2023.
209 funds tracked by Wall St. Rank held MaxLinear as of Q1 2024.

Based on Aristides Capital's 13F filing for Q1 2024, filed 15 May 2024.